{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:14:08Z","timestamp":1784740448949,"version":"3.55.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103912"],"award-info":[{"award-number":["82103912"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M700080"],"award-info":[{"award-number":["2021M700080"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QH302"],"award-info":[{"award-number":["ZR2020QH302"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Understanding the epidemiological characteristics of various cancers can optimize the prevention and control strategies in the national cancer control plan. This study aimed to report the burden differences, pattern trend, and potential risk factors of all neoplasm types in China in recent 30 years, and further compared with top economies in the world.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The disability-adjusted life-years (DALYs) and age-standardized DALY rate (ASDR) of all neoplasms with the attributable risk factors from 1990 to 2019 in China, Japan, European Union, USA, and the world were extracted from the Global Burden of Disease Study 2019. The temporal trend analysis was estimated using the joinpoint regression model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In 2019, about 251.4 million DALYs worldwide were caused by all neoplasms, and nearly 26.9% (67.5 million DALYs) occurred in China with the ASDR in 2019 of 342.09\/10 000, which was higher than European Union (334.25\/10 000), USA (322.94\/10 000), and Japan (250.36\/10 000). Although the cancer burden of the colorectum, non-Hodgkin lymphoma, oral cavity, ovary, and kidney in China was lower than in Japan, European Union and USA, the corresponding ASDR gradually increased in China over the past 30 years, but declined in the three developed areas. Around 46.29% of overall neoplasms DALYs in China in 2019 were attributed to 22 identified risk factors, and the specific risk attributable-fraction for several neoplasm types varied greatly in these regions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The ASDR of cancers of the lung, colorectum, pancreas, non-Hodgkin lymphoma, oral cavity, ovary, kidney, and chronic lymphoid leukemia increased in China compared to 30 years ago. With the population aging and the social transformation in China, the increasing burden of neoplasms and the changing spectrum of neoplasms suggest that effective comprehensive prevention and treatment measures should be adopted to reduce the burden, including public health education, strict tobacco-control policy, healthier lifestyles, along with expanding vaccination programs and early cancer screening.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2022.862165","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T05:47:18Z","timestamp":1653544038000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA"],"prefix":"10.3389","volume":"10","author":[{"given":"Xiaorong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019","volume":"8","author":"Kocarnik","year":"2021","journal-title":"J Am Med Assoc Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"J Am Med Assoc Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S1470-2045(21)00071-1","article-title":"The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases","volume":"22","author":"Anderson","year":"2021","journal-title":"Lancet Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health."},{"key":"B7","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1016\/j.vaccine.2018.02.003","article-title":"Status of HPV vaccine introduction and barriers to country uptake","volume":"36","author":"Gallagher","year":"2018","journal-title":"Vaccine."},{"key":"B8","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ccell.2020.03.006","article-title":"Response and resistance to BCR-ABL1-targeted therapies","volume":"37","author":"Braun TP Eide","year":"2020","journal-title":"Cancer Cell."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020","volume":"41","author":"Qiu","year":"2021","journal-title":"Cancer Commun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40364-021-00340-6","article-title":"Temporal trend of gastric cancer burden along with its risk factors in China from 1990 to 2019, and projections until 2030: comparison with Japan, South Korea, and Mongolia","volume":"9","author":"Yang","year":"2021","journal-title":"Biomark Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"B12","unstructured":"Global Cancer Observatory: Cancer Today.2020"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(20)30677-2","article-title":"Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study","volume":"396","author":"Vollset","year":"2020","journal-title":"Lancet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40880-019-0368-6","article-title":"Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/jn\/nxz095","article-title":"Past and recent salted fish and preserved food intakes are weakly associated with nasopharyngeal carcinoma risk in adults in Southern China","volume":"149","author":"Barrett","year":"2019","journal-title":"J Nutr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13045-019-0783-9","article-title":"Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study","volume":"12","author":"Lin","year":"2019","journal-title":"J Hematol Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"729","DOI":"10.21147\/j.issn.1000-9604.2020.06.06","article-title":"Epidemiology and risk factors of colorectal cancer in China","volume":"32","author":"Yang","year":"2020","journal-title":"Chin J Cancer Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"102068","DOI":"10.1016\/j.canep.2021.102068","article-title":"Burden of cancer and changing cancer spectrum among older adults in China: trends and projections to 2030","volume":"76","author":"Shi","year":"2022","journal-title":"Cancer Epidemiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"824464","DOI":"10.3389\/fmed.2022.824464","article-title":"Different trends in the incidence and mortality rates of prostate cancer between China and the USA: a joinpoint and age-period-cohort analysis","volume":"9","author":"He","year":"2022","journal-title":"Front Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"811044","DOI":"10.3389\/fpubh.2022.811044","article-title":"Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019","volume":"10","author":"Wang","year":"2022","journal-title":"Front Public Health."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD","year":"2020","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for accurate and transparent health estimates reporting: the GATHER statement","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/ijc.33617","article-title":"Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039","volume":"149","author":"Yu","year":"2021","journal-title":"Int J Cancer."},{"key":"B25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.lungcan.2020.12.007","article-title":"Temporal trends of the lung cancer mortality attributable to smoking from 1990 to 2017: a global, regional and national analysis","volume":"152","author":"Yang","year":"2021","journal-title":"Lung Cancer."},{"key":"B26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.21147\/j.issn.1000-9604.2020.02.01","article-title":"Cancer burden and trends in China: a review and comparison with Japan and South Korea","volume":"32","author":"Sun","year":"2020","journal-title":"Chin J Cancer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"879","DOI":"10.20892\/j.issn.2095-3941.2020.0387","article-title":"Cancer burden in China: trends, risk factors and prevention","volume":"17","author":"Sun","year":"2020","journal-title":"Cancer Biol Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/S0140-6736(21)01169-7","article-title":"Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/ntr\/ntab265","article-title":"Health effects of tobacco at the global, regional, and national levels: results from the 2019 Global Burden of Disease study","volume":"24","author":"He","year":"2021","journal-title":"Nicotine Tob Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/S0140-6736(17)30819-X","article-title":"Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015","volume":"389","author":"Collaborators","year":"2017","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.1002\/cam4.2477","article-title":"Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China","volume":"8","author":"Liu","year":"2019","journal-title":"Cancer Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/ijc.31043","article-title":"Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report","volume":"142","author":"Basu","year":"2018","journal-title":"Int J Cancer."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1001\/jamaoncol.2020.1460","article-title":"Cost-effectiveness of leveraging social determinants of health to improve breast, cervical, and colorectal cancer screening: a systematic review","volume":"6","author":"Mohan","year":"2020","journal-title":"J Am Med Assoc Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41568-020-00323-z","article-title":"Recent advances and discoveries in the mechanisms and functions of CAR T cells","volume":"21","author":"Larson","year":"2021","journal-title":"Nat Rev Cancer."},{"key":"B36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers."},{"key":"B37","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/ajh.25011","article-title":"Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring","volume":"93","author":"Jabbour","year":"2018","journal-title":"Am J Hematol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.7150\/jca.52186","article-title":"Secular trends in the incidence and survival of all leukemia types in the United States from 1975 to 2017","volume":"12","author":"Yang","year":"2021","journal-title":"J Cancer."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21147\/j.issn.1000-9604.2018.01.01","article-title":"Cancer incidence and mortality in China, 2014","volume":"30","author":"Chen","year":"2018","journal-title":"Chin J Cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1016\/S1470-2045(20)30073-5","article-title":"Cancer registration in China and its role in cancer prevention and control","volume":"21","author":"Wei","year":"2020","journal-title":"Lancet Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1016\/S2468-2667(19)30160-4","article-title":"Healthy China 2030: moving from blueprint to action with a new focus on public health","volume":"4","author":"Chen","year":"2019","journal-title":"Lancet Public Health."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1002\/cam4.3775","article-title":"Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years","volume":"10","author":"Li","year":"2021","journal-title":"Cancer Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/cac2.12143","article-title":"Predictions of mortality related to four major cancers in China, 2020 to 2030","volume":"41","author":"Li","year":"2021","journal-title":"Cancer Commun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.21147\/j.issn.1000-9604.2021.01.02","article-title":"Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: findings from Global Burden of Disease Study","volume":"33","author":"Zhang","year":"2021","journal-title":"Chin J Cancer Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"426","DOI":"10.2188\/jea.JE20200416","article-title":"Updated trends in cancer in Japan: incidence in 1985-2015 and mortality in 1958-2018-a sign of decrease in cancer incidence","volume":"31","author":"Katanoda","year":"2021","journal-title":"J Epidemiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"nu10020173","DOI":"10.3390\/nu10020173","article-title":"The role of the Japanese traditional diet in healthy and sustainable dietary patterns around the world","volume":"10","author":"Gabriel","year":"2018","journal-title":"Nutrients"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S0140-6736(19)32048-3","article-title":"Healthy China 2030: an opportunity for tobacco control","volume":"394","author":"Li","year":"2019","journal-title":"Lancet."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1016\/S2214-109X(18)30488-1","article-title":"Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment","volume":"7","author":"Chen","year":"2019","journal-title":"Lancet Glob Health."},{"key":"B49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/nsr\/nwv054","article-title":"Cancer prevention and control: alarming challenges in China","volume":"3","author":"Bode","year":"2016","journal-title":"Natl Sci Rev."},{"key":"B50","doi-asserted-by":"publisher","first-page":"800426","DOI":"10.3389\/fmed.2021.800426","article-title":"Spatiotemporal trends of colorectal cancer mortality due to low physical activity and high body mass index from 1990 to 2019: a global, regional and national analysis","volume":"8","author":"Man","year":"2021","journal-title":"Front Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S0140-6736(18)32849-6","article-title":"Cervical cancer prevention in China: a key to cancer control","volume":"393","author":"Zhao","year":"2019","journal-title":"Lancet."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1335","DOI":"10.1016\/S2214-109X(20)30277-1","article-title":"Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis","volume":"8","author":"Zou","year":"2020","journal-title":"Lancet Glob Health."},{"key":"B53","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.canlet.2021.02.017","article-title":"Cancer screening in China: the current status, challenges, and suggestions","volume":"506","author":"Cao","year":"2021","journal-title":"Cancer Lett."},{"key":"B54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40364-021-00266-z","article-title":"Targeted proteomics-derived biomarker profile develops a multi-protein classifier in liquid biopsies for early detection of esophageal squamous cell carcinoma from a population-based case-control study","volume":"9","author":"Yang","year":"2021","journal-title":"Biomark Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1038\/s41467-020-17316-z","article-title":"Non-invasive early detection of cancer four years before conventional diagnosis using a blood test","volume":"11","author":"Chen","year":"2020","journal-title":"Nat Commun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1136\/gutjnl-2018-317556","article-title":"Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study","volume":"68","author":"Cai","year":"2019","journal-title":"Gut."},{"key":"B57","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12885-021-08053-7","article-title":"A nomogram for screening esophageal squamous cell carcinoma based on environmental risk factors in a high-incidence area of China: a population-based case-control study","volume":"21","author":"Yang","year":"2021","journal-title":"BMC Cancer."},{"key":"B58","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S2213-8587(21)00083-8","article-title":"Mapping overdiagnosis of thyroid cancer in China","volume":"9","author":"Li","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/ijc.33602","article-title":"Breast cancer screening and overdiagnosis","volume":"149","author":"Bulliard","year":"2021","journal-title":"Int J Cancer."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1136\/gutjnl-2020-321600","article-title":"Global burden of oesophageal and gastric cancer by histology and subsite in 2018","volume":"69","author":"Arnold","year":"2020","journal-title":"Gut."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.862165\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T05:47:23Z","timestamp":1653544043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.862165\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":60,"alternative-id":["10.3389\/fpubh.2022.862165"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.862165","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]},"article-number":"862165"}}